Gabapentin and Calculus urinary - a phase IV clinical study of FDA data

Summary:

Calculus urinary is reported as a side effect among people who take Gabapentin (gabapentin), especially for people who are male, 50-59 old, have been taking the drug for 6 - 12 months also take Omeprazole, and have Progressive multiple sclerosis.

The phase IV clinical study analyzes which people have Calculus urinary when taking Gabapentin. It is created by eHealthMe based on reports of 313,421 people who have side effects when taking Gabapentin from the FDA, and is updated regularly.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,983 Gabapentin users. Check the latest studies of Gabapentin.

What is Calculus urinary?

Calculus urinary (stone in urinary system) is found to be associated with 328 drugs and 722 conditions by eHealthMe. Check the latest studies of Calculus urinary.

On Jul, 21, 2026

313,421 people reported to have side effects when taking Gabapentin.
Among them, 23 people (0.01%) have Calculus urinary.

Could Gabapentin cause Calculus urinary?

Among these 23 people:

How long have people been on Gabapentin when they have Calculus urinary? *

What is the gender of people who have Calculus urinary when taking Gabapentin? *

female: 44.44 %
male: 55.56 %

What is the age of people who have Calculus urinary when taking Gabapentin? *

What are other drugs people take besides Gabapentin? *

What are other side effects people have besides Calculus urinary? *

Sleep Disorder: 9 people, 39.13%
Urinary Tract Infection: 9 people, 39.13%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 9 people, 39.13%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 9 people, 39.13%
Atelectasis (partial or complete collapse of the lung): 8 people, 34.78%
Wheezing (a high-pitched whistling sound made while you breath): 7 people, 30.43%
Mitral Valve Incompetence (inefficient heart valve): 7 people, 30.43%
Lymphoedema (localized fluid retention and tissue swelling): 7 people, 30.43%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 7 people, 30.43%
Left Ventricular Hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart): 7 people, 30.43%

What are the existing conditions these people have? *

Progressive Multiple Sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord): 3 people, 13.04%
Migraine (headache): 2 people, 8.70%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 8.70%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 4.35%
High Blood Cholesterol: 1 person, 4.35%
Chronic Renal Failure (kidney failure): 1 person, 4.35%
Diabetes: 1 person, 4.35%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 1 person, 4.35%
Dyslipidaemia (abnormal amount of lipids): 1 person, 4.35%
Infantile Spasms: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and have Calculus urinary?

- Check whether Calculus urinary is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gabapentin:

Gabapentin (322,983 reports)

Browse all side effects of Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Calculus urinary:

Calculus urinary (328 drugs)

Browse all the conditions that are associated with Calculus urinary:

Calculus urinary (722 conditions)

Related publications that referenced our studies

de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on gabapentin (the active ingredients of Gabapentin) and Gabapentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.